Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved ...

Goldman’s profit roughly doubled in Q4 thanks in large part to surging revenues from deal-making, underwriting, and trading.

Goldman Sachs Group outperformed expectations in its fourth-quarter and full-year earnings with a robust financial showing ...

Goldman Sachs (NYSE: GS) shares traded higher after reporting strong Q4 and full-year 2024 results. Revenue, EPS, and stock ...

The Goldman Sachs Group, Inc.'s FY 2024 earnings show strong revenue and net earnings growth, with operating expenses at 3-year lows and profit margins at 3-year highs. Equities and FICC segments ...

Reports Q4 revenue $13.87B, consensus $12.46B ... Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on GS: Goldman Sachs NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

JPMorgan Chase, Goldman Sachs, Citi and Wells Fargo all reported fourth-quarter earnings Wednesday, and each banking behemoth ...

Goldman Sachs reported on Wednesday higher fourth-quarter profit above market estimates, powered by strong growth in revenues ...

Goldman Sachs said its profit more than doubled in the fourth quarter, boosted by companies’ growing appetite for dealmaking.

Goldman Sachs BDC's portfolio has diversified sector exposure, with notable changes in exposure since last coverage. Read why ...

Analysis of JPMorgan Chase and Goldman Sachs Q4 2024 earnings forecasts, including key metrics, analyst expectations and ...

Goldman Sachs' Q4 2024 earnings per share (EPS) soared to $11.95, significantly surpassing the expected $8.21. Revenue in Q4 hit $13.87 billion, exceeding estimates of $12.36 billion. Fourth ...